United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 400 mg - cimetidine tablets usp are indicated in: cimetidine is contraindicated for patients known to have hypersensitivity to the product.

United States - English - NLM (National Library of Medicine)

proficient rx lp - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 400 mg - cimetidine tablets are indicated in: cimetidine is contraindicated for patients known to have hypersensitivity to the product.

United States - English - NLM (National Library of Medicine)

hospira, inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - injection, solution - 6 mg in 1 ml - cimetidine hydrochloride injection is indicated in: (1) short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration − duodenal ulcer). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. (2) maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg h.s. for periods of up to five years. (3) short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. (4) prevention of upper gastrointestinal bleeding in critically ill patients. (5) the treatment of pathological hypersecretory conditions

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 200 mg - cimetidine tablets are indicated in: 1. short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine tablets at full dosage for longer than 6 to 8 weeks (see dosage and administration: duodenal ulcer). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of cimetidine tablets and antacids is not recommended, since antacids have been reported to interfere with the absorption of cimetidine. 2. maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine tablets 400 mg at bedtime for periods of up to 5 years. 3. short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. 4. erosive gastroesophageal reflux (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated for 12 weeks for healing of lesions and control of symptoms. the use of cimetidine tablets beyond 12 weeks has not been established (see dosage and administration: gerd). 5. the treatment of pathological hypersecretory conditions (i.e., zollinger-ellison syndrome, systemic mastocytosis, multiple endocrine adenomas). cimetidine tablets are contraindicated for patients known to have hypersensitivity to the product.

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 300 mg - cimetidine tablets usp are indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration , duodenal ulcer ). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg at bedtime for periods of up to five years. - short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. - erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated for 12 weeks for healing of

United States - English - NLM (National Library of Medicine)

blenheim pharmacal, inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 300 mg - cimetidine tablets are indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration , duodenal ulcer ). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg at bedtime for periods of up to five years. - short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. - erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated

United States - English - NLM (National Library of Medicine)

avkare, inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 400 mg - cimetidine tablets are indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration , duodenal ulcer ). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg at bedtime for periods of up to five years. - short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. - erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 300 mg - cimetidine tablets are indicated in: 1) short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration , duodenal ulcer ). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. 2) maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg at bedtime for periods of up to five years. 3) short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than eight weeks. 4) erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated for twelve weeks for healin

United States - English - NLM (National Library of Medicine)

dispensing solutions, inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 400 mg - cimetidine tablets are indicated in: 1) short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration , duodenal ulcer ). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. 2) maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg at bedtime for periods of up to five years. 3) short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than eight weeks. 4) erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated for twelve weeks for healin

United States - English - NLM (National Library of Medicine)

akorn operating company llc - cimetidine hydrochloride (unii: wf10491673) (cimetidine - unii:80061l1wgd) - cimetidine 300 mg in 5 ml - cimetidine hydrochloride oral solution is indicated in: (1) short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration-duodenal ulcer). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. (2) maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg h.s. for periods of up to 5 years. (3) short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. (4) erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated for 12 weeks for hea